Access to cancer treatment in non-metropolitan areas of Australia
Implications for cancer-related treatment outcomes
Around 50% of males and 33% of females in Australia will develop cancer within their lifetime. 20% will subsequently die from cancer before they turn 85 years of age, making cancer the second leading cause of mortality in Australia after cardiovascular disease.
This study, for Amgen Australia Pty Ltd, evaluates the literature surrounding cancer treatment and cancer outcomes in non-metropolitan Australia. It also quantifies access to cancer-related treatments – access defined as the distance to the nearest place of cancer-related treatment, including the nearest infusion service for the intravenous delivery of cancer-related treatment (i.e., chemotherapy) and radiotherapy service.
The report documents the large disparities in cancer outcomes between people living in metropolitan versus non-metropolitan regions. It is structured as follows:
- Executive Summary
- Section1: An overview of cancer
- Section 2: A literature review on access to cancer treatment
- Section 3: Mapping access to cancer treatment
- Section 4: Focusing on specific Federal electoral divisions